MRK News 57.25 04/21/2014 21:37:13 Merck & Company (MRK)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Merck & Company (MRK) 57.25 $MRK

Dow Climbs As Pharma Stocks Jump, but Will Drug M&A Hurt UnitedHealth?
Dan Caplinger, The Motley Fool - Motley Fool - 1 hr 33 mins ago
The Dow Jones Industrials rose more than 40 points Monday as investors continued to ride the wave of enthusiasm that has accompanied the beginning of earnings season. Leading the way higher for the Dow were Pfizer and Merck , which gained 2%...

Valeant to bid for Botox maker Allergan
By KEN SWEET and MATTHEW PERRONE - AP - 2 hrs 28 mins ago
NEW YORK (AP) — Valeant Pharmaceuticals has teamed up with activist investor Bill Ackman in a bid for Botox maker Allergan that could be worth about $40 billion.

Pfizer, Inc. Rebuffed: Is AstraZeneca plc Worth Another Try?
Stephen D., Simpson,, The Motley Fool - Motley Fool - Mon Apr 21, 5:30PM CDT
Big-time pharma mergers have had a mixed track record, with large combinations often leading to significant cost reductions (and firings) in sales and administration but at the cost of large disruptions to R&D. Pfizer is apparently not afraid...

Merck Rises 1.38% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Mon Apr 21, 4:03PM CDT
Merck (NYSE:MRK) traded in a range yesterday that spanned from a low of $56.40 to a high of $57.30. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $57.00 on volume of 6.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

After Yesterday's Rally of 1.38% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon Apr 21, 4:03PM CDT
Merck (NYSE:MRK) traded in a range yesterday that spanned from a low of $56.40 to a high of $57.30. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $57.00 on volume of 6.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Merck among NASA Cargo Launching to Space Station
PR Newswire - Mon Apr 21, 3:15PM CDT
When the SpaceX-3 cargo resupply mission launched to the International Space Station April 14, an experiment designed by Merck Research Laboratories of Kenilworth, N.J., was among the cargo headed to space.

Emerging 'Superbugs' -- and Why Investors Should Care
at The Street - Mon Apr 21, 11:23AM CDT
Antibiotic-resistant 'superbugs' are spreading, and drug companies and their investors should take notice.

Interesting May Stock Options For MRK
at The Street - Mon Apr 21, 11:08AM CDT
Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Merck & Co., Inc . So this week we highlight one interesting put contract, and one interesting call contract, from the May...

Pfizer, AstraZeneca Rise On Report Of Merger Talks
at Investor's Business Daily - Mon Apr 21, 10:13AM CDT
Big pharmas Pfizer (PFE) and AstraZeneca (AZN) were both up in early trading on the stock market today after word got out Sunday that Pfizer had offered $101 billion to buy its rival. Citing unnamed sources, the U.K.'s Sunday Times said that the two...

Johnson & Johnson's New Diabetes Drug: A Blockbuster in the Making?
Todd Campbell, The Motley Fool - Motley Fool - Mon Apr 21, 7:47AM CDT
The market for diabetes treatment has never been bigger, and that is propelling sales of Johnson & Johnson 's Invokana higher. According to data from  Express Scripts , the nation spent 14% more on diabetes drugs in 2013 than it did in 2012....

3 Reasons the Market Is Down on Gilead Sciences
Brian Orelli, The Motley Fool - Motley Fool - Fri Apr 18, 5:30PM CDT
After a solid two-year run, Gilead Sciences   has fallen from investors graces, down for the year. The biotech has become increasingly reliant on its hepatitis C drug Sovaldi, with competition from  AbbVie and  Merck  around the corner. In the...

Jim Cramer: We're in the Grips of a Struggle
at The Street - Fri Apr 18, 12:51PM CDT
Companies that are inventing incredibly important drugs go down almost every day.

Biohazard? Gilead Leads 5 Big-Cap Biotech Earnings
at Investor's Business Daily - Fri Apr 18, 11:12AM CDT
Can biotech stocks bounce back? As recently as last month, the Medical-Biomed/Biotech group was ranked No. 1 out of IBD's 197 industries. But it's been dead last over the last four weeks, plunging 22.1%. That partly reflects growth stocks overall...

FDA Approves Merck's RAGWITEK(TM) (Short Ragweed Pollen Allergen Extract) Sublingual Tablet as Immunotherapy to Treat Short Ragweed Pollen-Induced Allergic Rhinitis with or without Conjunctivitis in Adults
Business Wire - Thu Apr 17, 5:22PM CDT
Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved RAGWITEK(TM) (Short Ragweed Pollen Allergen Extract) Tablet for Sublingual Use (12 Amb a 1-U). RAGWITEK is an allergen extract indicated as immunotherapy for the treatment of short ragweed pollen-induced allergic rhinitis with or without conjunctivitis confirmed by positive skin test or in vitro testing for pollen-specific IgE antibodies for short ragweed pollen. RAGWITEK is approved for use in adults 18 through 65 years of age. RAGWITEK is not indicated for the immediate relief of allergic symptoms.

Has A Streamlined FDA Raised The Value Of Drug Stocks?
at Investor's Business Daily - Thu Apr 17, 4:33PM CDT
Last month, three Democrats from the U.S. Congress sent a now-famous letter to Gilead Sciences (GILD) questioning the $84,000 price of its new blockbuster hepatitis C medicine, Sovaldi. Among the reasons raising suspicions that the price didn't need...

FDA OKs Merck tablet to reduce ragweed allergies
By The Associated Press - AP - Thu Apr 17, 4:11PM CDT
WHITEHOUSE STATION, N.J. (AP) — U.S. regulators have again approved a Merck & Co. tablet for gradually reducing seasonal allergies, this time for ragweed pollen.

ALK announces FDA approval for Merck's ragweed sublingual allergy immunotherapy tablet RAGWITEK(r)
GlobeNewswire - Thu Apr 17, 2:13PM CDT
ALK (ALKBC / OMX: ALK B / AKABY / AKBLF) today announced that the US Food and Drug Administration (FDA) has approved the Biologic License Application (BLA) for RAGWITEK.

Johnson & Johnson's 3 Major Strengths
Peter Stephens, The Motley Fool - Motley Fool - Thu Apr 17, 1:30PM CDT
I recently wrote a mini-series on Johnson & Johnson  , where I focused on each of its three segments: pharmaceuticals, consumer goods, and medical devices. Now seems like an opportune moment to check out the strengths of J&J as a group, with...

If This Biotech Drops Much Further I'm Going to Buy It!
Sean Williams, The Motley Fool - Motley Fool - Thu Apr 17, 12:05PM CDT
We've seen a little bit of a relief rally over the past couple of days in the overall market with the start of earnings season giving investors hope that the U.S. economy and corporations can keep motoring higher. On the all, though, it's been a...

Merck Serono's President & CEO Belen Garijo has Been Appointed to Board of Directors of L'Oreal
PR Newswire Europe - Thu Apr 17, 11:39AM CDT
DARMSTADT, Germany and PARIS, April 17, 2014 /PRNewswire/ --
Scroll down for more posts ▼

Top 10 Most Recent News Articles

D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 191

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 118

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 261

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 276

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
QuidelOrtho Faces Fresh Scrutiny Over Savanna Claims

Updated Category News Views 235

A diagnostic launch can turn into a corporate migraine with frightening speed, and QuidelOrtho is staring at exactly that sort of mess. Kahn Swick & Foti said on November 20, 2026, that it has begun investigating whether QuidelOrtho officers or directors breached fiduciary duties or otherwise violated state or federal law. This is not a finding of wrongdoing. It is an...

Continue Reading
Charter Investigation Puts ACP Exit Claims Under Lens

Updated Category News Views 258

Charter’s ACP hangover has grown from an operating headache into a governance question. Kahn Swick & Foti said on November 20, 2026, that it has begun investigating whether Charter Communications officers or directors breached fiduciary duties or otherwise broke state or federal law. That is not a finding of wrongdoing, and investors ought to keep that distinction...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 176

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 184

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 47

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
WaterField’s Nova Case Bets on Better Handheld Carry

Updated Category News Views 211

Tiny handhelds have spawned a surprisingly fussy luggage problem: protection without the clown-show aesthetic. WaterField Designs is taking a clean swing at that with a custom case for the Retroid Pocket Nova, a sleeve-like carrier built around the device rather than some generic pouch that leaves everything rattling around inside. This is not a market-moving corporate...

Continue Reading

Top 5 Most Recently Viewed Articles

Cameco Prepares for Leadership Transition at Westinghouse Electric

Updated Category News Views 149

Cameco Acknowledges Leadership Changes at Westinghouse Cameco (TSX: CCO; NYSE: CCJ) has made a significant acknowledgment regarding the leadership transition at Westinghouse Electric Company. This moment marks a pivotal change as Patrick Fragman announces his decision to step down from his role as President and CEO of Westinghouse. Effective March 31, 2025, Patrick will...

Continue Reading
Discover Innovations at Taiwan Innotech Expo 2025 in AI

Updated Category News Views 296

Taiwan Innotech Expo 2025 Highlights The Taiwan Innotech Expo (TIE) is set to showcase the critical role of artificial intelligence (AI) in transforming various industries. Hosted in Taipei, this annual event brings together influential government agencies, including the Ministry of Economic Affairs and the National Science and Technology Council. The expo will open its...

Continue Reading
Explore Antarctica: A Unique Journey with Atlas Ocean Voyages

Updated Category News Views 225

Unveiling a Unique Antarctic Adventure Atlas Ocean Voyages, known for its intimate luxury expeditions, is set to elevate its offerings with a remarkable new program on board the luxury ship, World Traveller. This journey promises to provide guests not only breathtaking landscapes but also enriching experiences through collaboration with renowned photographer Karim Iliya...

Continue Reading
atNorth's Bold Expansion: Norway Meets Mega Data Site

Updated Category News Views 48

Setting the Stage in Haugaland Here's a bold move from atNorth that's got folks talking. This Nordic heavyweight isn't just dancing around the edges; they're making a big splash by staking their claim in Norway with a mega site that’s got ‘future’ written all over it. We’re talking a data center in Haugaland, starting with 120MW and aiming for a solid 350MW once...

Continue Reading
Volvo Group's CES Keynote: Paving the Path to Sustainability

Updated Category News Views 192

Volvo Group Spearheads Sustainability at CES At CES, the Consumer Electronics Show, Volvo Group’s President and CEO, Martin Lundstedt, captured the audience with a strong call to action regarding the future of transportation and infrastructure. Lundstedt emphasized the dire need for urgent changes in the industry to combat climate change, setting the tone for a vibrant...

Continue Reading